Oncoheroes Biosciences 10/2/23 Oncoheroes Biosciences 10/2/23 FDA Allows Oncoheroes to Begin Two Pediatric Oncology Clinical Trials Read More Oncoheroes Biosciences 9/22/22 Oncoheroes Biosciences 9/22/22 FDA Grants Rare Pediatric Disease Designation (RPDD) to dovitinib for osteosarcoma Read More
Oncoheroes Biosciences 10/2/23 Oncoheroes Biosciences 10/2/23 FDA Allows Oncoheroes to Begin Two Pediatric Oncology Clinical Trials Read More
Oncoheroes Biosciences 9/22/22 Oncoheroes Biosciences 9/22/22 FDA Grants Rare Pediatric Disease Designation (RPDD) to dovitinib for osteosarcoma Read More
